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ABSTRACT
Patients suffering from spinal cord injury (SCI) still have a dismal prognosis. Despite all the
efforts developed in this area, currently there are no effective treatments. Therefore, cell thera-
pies have been proposed as a viable alternative to the current treatments used. Adipose tissue-
derived stromal cells (ASCs) and olfactory ensheathing cells (OECs) have been used with promis-
ing results in different models of SCI, namely due to the regenerative properties of the secre-
tome of the ﬁrst, and the guidance capability of the second. Using an in vitro model of axonal
growth, the dorsal root ganglia explants, we demonstrated that OECs induce neurite outgrowth
mainly through cell-cell interactions, while ASCs’ effects are strongly mediated by the release of
paracrine factors. A proteomic analysis of ASCs’ secretome revealed the presence of proteins
involved in VEGF, PI3K, and Cadherin signaling pathways, which may be responsible for the
effects observed. Then, the cotransplantation of ASCs and OECs showed to improve motor deﬁ-
cits of SCI-rats. Particular parameters of movement such as stepping, coordination, and toe
clearance were improved in rats that received the transplant of cells, in comparison to non-
treated rats. A histological analysis of the spinal cord tissues revealed that transplantation of
ASCs and OECs had a major effect on the reduction of inﬂammatory cells close the lesion site.
A slight reduction of astrogliosis was also evident. Overall, the results obtained with the present
work indicate that the cotransplantation of ASCs and OECs brings important functional beneﬁts
to the injured spinal cord. STEM CELLS 2018;36:696–708
SIGNIFICANCE STATEMENT
Spinal cord injury (SCI) still has no cure and cellular transplantation has been considered a valid
alternative for SCI treatment. This study shows that adipose tissue-derived stromal cells (ASCs)
and olfactory ensheathing cells (OECs) induce neurite outgrowth of dorsal root ganglia explants
through distinct mechanisms. The cotransplantation of ASCs and OECs into a rat model of SCI
led to functional improvements. Additionally, there was a reduction of inflammatory cells close
to the injury site and ASCs were integrated in the spinal cord tissue, 8 weeks post-injury. Over-
all, the transplantation of ASCs and OECs is a promising strategy for SCI repair.
INTRODUCTION
Spinal cord injury (SCI) is one of the most dev-
astating conditions of the CNS for which there
is still no cure. Sensorial and motor function
deﬁcits, cardiac and respiratory complications,
sexual and urinary dysfunctions, and some-
times depression are among the consequences
of SCI. The treatment to this condition is
mainly based on palliative care. However,
there are new therapies currently under inves-
tigation aiming to promote functional recovery
after SCI through different neurorestorative
mechanisms [1, 2]. From those, cellular trans-
plantation emerges as a promising tool, either
by replacing the damaged nervous tissue or
alternatively potentiating endogenous neuronal
regeneration by exerting a neurotrophic and/
or neuroprotective role.
In this context, mesenchymal stromal cells
(MSCs) have gained increased notoriety, much
due to their supportive character [3]. These
cells, ﬁrst characterized by Friedenstein et al.
(1974) [4], are identiﬁed by their multipotency,
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REGENERATIVE MEDICINE
adhesion to plastic, and positive/negative expression of some
speciﬁc markers [5]. Adipose tissue-derived stromal cells
(ASCs) are a type of MSCs derived from an abundant and
accessible source (adipose tissue). Moreover, ASCs have
shown to possess an immunomodulatory proﬁle [6, 7], in
addition to a neurotrophic role, providing protection, survival,
and differentiation of different cells and tissues [8, 9]. All
these effects have been associated to ASCs’ secretome, that
is, the set of molecules that these cells secrete to the extra-
cellular milieu [6, 10, 11]. ASCs have been applied to animal
models of SCI with promising results [12, 13]. In a cervical SCI
model, transplanted ASCs modulated the structure of the glial
scar and stimulated axonal sprouting [12]. In a thoracic com-
pression injury model, ASCs were capable of promoting func-
tional recovery in addition to tissue preservation and axonal
regeneration [13]. Regarding human clinical trials, the autolo-
gous transplantation of ASCs, obtained from lipoaspirates,
into SCI patients was free of serious adverse events and some
patients showed mild improvements in motor and sensory
scores [14].
Olfactory ensheathing cells (OECs) have also gathered par-
ticular attention due to their potential for SCI treatment [15].
OECs are a speciﬁc type of cells present in the olfactory sys-
tem that support the constant neuronal regeneration in the
transition between the PNS and the CNS [16]. Considering
OECs’ role in their native olfactory system, Ramon-Cueto and
colleagues [17, 18] transplanted these cells into different
models of CNS injury in rats, demonstrating improved axonal
regeneration after a lesion. Following their pioneering work,
different preclinical studies managed to reproduce the beneﬁ-
cial effects of OECs grafts, including partial recovery of motor
function [19–21], even under a chronic SCI lesion [22]. Among
several interesting properties, OECs are capable of: (a) bridg-
ing the lesion site, by interacting with endogenous astrocytic
processes [23], (b) myelinating previously demyelinated
regions of the spinal cord [24], (c) having a phagocytic activ-
ity, removing degenerating axons [25, 26], and (d) modulating
the glial scar as well as promoting angiogenesis [27]. Trans-
plantation of OECs in humans has also already been tested
[28, 29]. The use of these cells was shown to be safe and in
some cases patients presented improvements in motor and
light touch scores [30].
In addition to the beneﬁcial properties above described,
ASCs and OECs have the advantage of being good candidates
for autologous transplantation, avoiding ethical concerns.
Moreover, previous work from our group showed that ASCs
and OECs present positive paracrine interactions, with
improved proliferation and metabolic activity of both cells
when seeded in an indirect coculture system [31]. In this
work, we aimed to assess the regenerative potential of the
combined application of ASCs and OECs either in an in vitro
model of axonal regeneration as well as in an in vivo model
of SCI.
MATERIALS AND METHODS
Cell Isolation and Culture
Human ASCs were isolated according to Dubois et al. [32]
with a collaboration with LaCell LLC. The culture of these cells
is described in Supporting Information. OECs were harvested
and cultured according to a previously described protocol
[33]. Details about the culture of these cells are described in
Supporting Information.
Secretome Collection
For the secretome used in in vitro experiments, ASCs at sixth
passage (P6) were seeded at 4,000 cells per cm2 density in
cell culture ﬂasks, with their normal growth medium (Support-
ing Information). Seventy-two hours after seeding, the media
was removed, and cells were washed three times with
phospate-buffered saline (PBS) without Ca21/Mg21 (Invitro-
gen, USA), followed by neurobasal medium (Invitrogen) with
1% penicillin/streptomycin (pen/strep, Invitrogen). Then, fresh
neurobasal media (with 1% pen/strep) was added to the cells.
Twenty-four hours later, this media was collected (now called
conditioned media [CM]), ﬁltered (0.2 mm pore diameter),
and frozen in liquid nitrogen for later application.
OECs isolated and puriﬁed as described in supporting
information were seeded at 40,000 cells per cm2 density in
ﬁbronectin-coated cell culture ﬂasks, with their normal growth
medium (Supporting Information). Then, the same condition-
ing protocol was followed as for ASCs, in order to collect
OECs’ secretome.
As a control, ﬂasks without cells but with neurobasal
media (with 1% pen/strep) were kept for 24 hours at the
same conditions, before being ﬁltered and frozen in liquid
nitrogen.
Proteomic Data Analysis
Proteomic data of ASCs’ secretome, previously obtained from
Pires et al. [34] and newly obtained OECs proteomic data were
analyzed using two distinct approaches. In the ﬁrst approach,
the Protein Analysis Through Evolutionary Relationships (PAN-
THER) classiﬁcation system (http://pantherdb.org) was used to
identify the signaling pathways related with ASCs and OECs
secreted proteins. Then, the main hits obtained were grouped
according to their main function and represented in a pie chart.
In the second approach, a PANTHER overrepresentation test
was performed to highlight the most representative Reactome
pathways. This test was performed using the following criteria:
entire human database as background list; applying a Binomial
distribution test with Bonferroni correction for multiple compar-
isons and a cut-off of .05 p-value.
Dorsal Root Ganglia Isolation and Culture
with ASCs/OECs
OECs were ﬁrst isolated and puriﬁed as described in supporting
information. They were seeded at 20,000 cells per cm2 density on
ﬁbronectin-coated 24 well plates, with their normal growth
medium. Seventy-two hours after seeding, ASCs were seeded on
top of OECs cultures (in coculture group) or on ﬁbronectin-coated
24 well plates, at 7,500 cells/cm2 density. The growth medium of
OECs was used for this step, since previous experiments (nonpub-
lished data) showed that ASCs proliferation and metabolic viability
were not altered in this medium. Twenty-four hours later, dorsal
root ganglia (DRG) explants were isolated according to Allodi et al.
[35] and placed on top of all experimental groups (ASCs and OECs
alone, or coculture). Thoracic DRG explants were isolated from P5-
P7 rats and cleaned to remove peripheral processes. Then they
were placed over the experimental conditions under study. The
medium was changed to DRGs normal growth medium:
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neurobasal medium supplemented with 6 mg/ml D-glucose (Sigma,
USA), 1% pen/strep, 2% B27 (Invitrogen) and 2 mM L-Glutamine
(Invitrogen). Some DRG explants were additionally placed on a
control group without cells, cultured with normal growth medium.
The cultures were kept for 4 days, with daily medium exchanges.
After ﬁxation, an ICC for neuroﬁlament (NF) was performed and
samples imaged with an Olympus IX81 ﬂuorescence microscope.
The analysis was made using the software ImageJ (NIH).
DRG Isolation and Culture with ASCs/OECs Secretome
Collagen hydrogel droplets were used as a matrix for DRGs
adhesion and growth. The matrix was prepared by mixing rat
tail collagen type I (3.61 mg/ml; 89.6% [vol/vol]; BD Biosci-
ences, USA) with DMEM concentrated medium (103; 10%
[vol/vol]; Invitrogen) and a solution of NaHCO3 (7.5% [wt/vol];
0.4% [vol/vol]). After mixing, collagen droplets were incubated
for 2 hours at 378C, 5% CO2 (vol/vol). Then, DRGs were iso-
lated and placed on top of previously prepared collagen drop-
lets with their normal growth medium. Twenty-four hours
later, this medium was replaced with the CM from ASCs,
OECs, or the control group. In the moment of media addition,
both secretomes, as well as the control, were further supple-
mented with B27, L-Glutamine, and Glucose. DRGs were kept
in culture for 5 days and media were replaced once, at day 3.
After 5 days, samples were ﬁxed and subjected to an ICC for
NF. Images were obtained through confocal microscopy
(Olympus FV1000).
Immunocytochemistry
ICC protocols were used to identify DRG neurite projections
in culture, applying the mouse anti-NF 200 kDa antibody
(1:200, Millipore, USA). Details can be found in Supporting
Information.
DRG Outgrowth Analysis
To calculate the area occupied by the neurites, Neurite J plu-
gin for ImageJ was applied [36]. Initially, the body area of the
explant was deﬁned and then the threshold contrast was
adjusted to highlight the neurites formed from the DRG body.
After determining the scale, the plugin automatically con-
verted the images to 8 bits. Finally, using the menu “analyze
particles” the software automatically calculated the areas
occupied by the neurites, using the dark background as con-
trast. In order to calculate the number of intersections, Neu-
rite J plugin was used.
In Vivo Proof of Concept
Animals and Groups. Eight-weeks-old female Wistar rats
(Charles River, France), housed in light and temperature con-
trolled rooms and fed with standard diet, were used in the in
vivo studies. Handling was performed for 3 days before the
surgeries. Animals were divided in three distinct groups
according to the respective treatment/procedure: (a) Animals
subjected to SCI with no treatment (SCI, n5 5), (b) SCI ani-
mals treated with a transplantation of ASCs and OECs (Cells,
n5 5), and (c) Animals with laminectomy only, without SCI
(Sham, n5 5). In the cells-treated group, a total of 40,000
OECs and 40,000 ASCs were injected per animal, divided by
two injections, 2 mm rostral and 2 mm caudal to the lesion,
using a Hamilton syringe.
Spinal Cord Injury Surgery. All animals were anesthetized by
intraperitoneal injection of a mixture (1.5:1) of ketamine
(100 mg/ml, Imalgene/Merial, France) and medetomidine
hydrochloride (1 mg/ml, Domitor/Pﬁzer, USA). Once anesthe-
tized, fur was shaved from the surgical site and the skin disin-
fected with ethanol 70% and chlorohexidine. Then, a dorsal
midline incision was made from T7-T13 and the paravertebral
muscles retracted. A laminectomy was performed at T10 level,
in which the spinous processes were removed and the spinal
cord exposed. A unilateral defect (hemisection) on the left side
of the spinal cord was done, removing 2–3 mm of nervous tis-
sue. After the respective treatment, paravertebral muscles and
skin were closed with Vicryl sutures (Johnson and Johnson,
USA). The incision of SCI control animals was closed after injury
without treatment. Post-operative care was given to all SCI rats
(protocol described in Supporting Information).
Behavioral Analysis
BBB Test. To evaluate motor behavior the Basso, Beattie,
Bresnahan Locomotor Rating Scale (BBB) [37] was used every
week, starting exactly 1 week post-injury, up to a total of
8 weeks. Locomotion of the affected hindlimb is rated by two
blinded observers in a 4-minutes test.
Activity Box Test. General locomotion activity was measured
by assessing the number of rearings and distance travelled in
a closed arena, 5 and 8 weeks post-injury [38]. The arena
(43.2 cm 3 43.2 cm) has transparent acrylic walls (Med Asso-
ciates Inc., USA) and is placed in a brightly illuminated room.
Animals started the test at the arena’s center and were given
5 minutes to explore it.
Swimming Test. Eight weeks after the injury, spontaneous
motility was also measured through a swimming test. Each
animal was placed at the border of a pool with 170 cm of
diameter, having a central platform with 12 cm of diameter.
Each animal had three trials to ﬁnd the platform, with each
trial having a maximum of 2 minutes. The average velocity of
these animals was determined through an infra-red camera,
associated to the VideoTrack software (Viewpoint, France).
Immunohistochemistry. After obtaining the spinal cord sec-
tions (detailed in Supporting Information) immunohistochem-
istry (IHC) protocols were performed. The following primary
antibodies were used: (a) mouse anti-CD11b/c (Pharmingen,
USA), (b) rabbit anti-rat glial ﬁbrillary acidic protein (GFAP,
Dako, Denmark), (c) mouse anti-NF (Millipore), (d) rabbit anti-
tyrosine hydroxylase (TH, Millipore), and (v) mouse anti-nuclei
antibody (HuNu, Millipore). IHC and staining quantiﬁcation
protocols can be found in Supporting Information.
Statistical Analysis
All statistical analyses were performed using GraphPad Prism
version 5.00 for Windows (GraphPad Software). Differences
among groups were assessed by: (a) one-way ANOVA test in
results presented in Figures 1B, 1C, 3B, and 5C, and 6, (b)
two-way ANOVA in results presented in Figures 1D, 3C, 4, and
5A, 5B. One or two-way ANOVA tests were followed by the
Bonferroni post-hoc test. A p-value of .05 was set as the cri-
teria for statistical signiﬁcance.
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Figure 1. Two-dimensional direct contact cultures of ASCs, OECs, or both with dorsal root ganglia (DRG) explants. In direct culture con-
ditions, OECs have a higher impact on neurite outgrowth in comparison to ASCs. (A): Representative ﬂuorescence microscopy images of
DRG explants and their neurites stained with neuroﬁlament (in green), for each of the groups under evaluation. (B): Quantiﬁcation of
the neurite area with ImageJ software. (C): Quantiﬁcation of the distance of the longest neurite (Dmax) with Neurite J plugin. (D):
Analysis of the arborization patterns produced by each experimental group. Scale: 1 mm; Values are shown as mean6 SEM (n5 3
independent experiments); *, p .05; **, p .01; ***, p .001. In graph (D), the differences between groups are highlighted according
to their group colors. Abbreviations: ASCs, adipose tissue-derived stromal cells; OECs, olfactory ensheathing cells.
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RESULTS
Effects of Direct Coculture of ASCs/OECs with DRGs
In order to assess the effects of both cell types on neuritogene-
sis, we started by performing direct cultures of both cells (alone
or in combination) with DRG explants. After 4 days of culture, it
was visible a clear effect of OECs (or coculture of OECs with
ASCs) on neurite outgrowth from the explants (Fig. 1A). The
area occupied by the neurites cultured with OECs (4.16 0.8 3
106 mm2) was similar to the area of the neurites from the cocul-
ture group (4.36 0.6 3 106 mm2), but signiﬁcantly higher in
comparison to ASCs group (1.26 0.3 3 106 mm2) or the control
group (0.46 0.13 106 mm2) (Fig. 1B). After analyzing the arbor-
ization pattern of each experimental group, it was possible to
observe that coculture and OECs groups present signiﬁcantly
more intersections (Fig. 1D), which is a synonym of higher rami-
ﬁcation of the neurites formed. In addition, the neurites formed
in these groups extended to longer distances than ASCs group
(OECs: 3,4336 400 mm; Coculture: 3,0936 239 mm; ASCs:
2,4466 274 mm); or the control (1,2316 161 mm) (Fig. 1C).
After a more detailed analysis to the cellular disposition
and neurite formation it becomes clear that newly formed
neurites followed very closely OECs direction and orientation,
which was not so evident in cultures with ASCs (Fig. 2). These
results might indicate that the inﬂuence of OECs on neurite
outgrowth, under a direct contact paradigm, is higher in com-
parison to ASCs. In particular, OECs seem to have a guidance
capacity, favoring the growth of neurites toward OECs-
enriched regions.
Effects of ASCs/OECs Secretome on DRGs Neurite
Formation
Using the same in vitro model, we cultured DRG explants
without the presence of the cells, but in contact with the fac-
tors secreted by ASCs or OECs. In this context, and after 5
days in contact with ASCs or OECs secretome, the only group
that presented relevant neurite formation was the condi-
tioned media (CM) of ASCs (total area: 32,6756 11,869 mm2).
OECs secretome and the control did not induce any signiﬁcant
neurite extension (Fig. 3A–3C). In order to characterize and
explore the role of ASCs’ and OECs’ secretome on the effects
observed, a set of proteomic data previously obtained from
ASCs, was re-analyzed [34] and a new proteomic analysis was
performed for OECs secretome (Supporting Information Tables
2 and 3). The proteins identiﬁed in the secretome of ASCs
may be involved in several different pathways (Fig. 3D), from
which we highlight the VEGF and Cadherin signaling path-
ways, as well as the PI3 kinase pathway, which are responsi-
ble for a myriad of cellular processes, including neurite
outgrowth and neuronal protection. Proteins involved in neu-
ronal communication pathways are also present in ASCs’
secretome. On the other hand, even though OECs secretome
also contains proteins related to neurite outgrowth pathways,
these seem less relevant (Fig. 3D). For example, the VEGF sig-
naling pathway is absent of the main hits analysis for signal-
ing pathways. A complementary analysis, based on a
PANTHER overrepresentation test, also highlights the impor-
tance of reactome pathways associated with neurite out-
growth (Supporting Information Table 1).
Figure 2. Culture of dorsal root ganglia (DRG) explants with OECs or ASCs. Neurites (in green) formed by the DRG follow the orientation of
OECs (in red, upper right panel). In the case of ASCs (lower panel), it seems that the neurites formed do not follow the direction and orienta-
tion of cells as clearly as in OECs cultures. Abbreviations: ASCs, adipose tissue-derived stromal cells; OECs, olfactory ensheathing cells.
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ASCs and OECs Treatment Leads to an Improvement
of Locomotion in SCI Rats
Taking into account the results obtained in vitro, we
decided to move to an in vivo proof of concept, by
transplanting both cell types into SCI animals. We divided
the animals in three different groups: SCI rats without
treatment (hemisection–HS group), SCI rats transplanted
with ASCs/OECs (Cells group), and noninjured rats (laminec-
tomy only–Sham group).
After 8 weeks, the BBB analysis revealed that animals
treated with cells displayed improved motor outcomes, when
comparing to nontreated animals (Fig. 4B, 4C).
Figure 3. Cultures of dorsal root ganglia (DRG) explants with the secretome derived from different cell sources and proteomic analysis.
(A): Representative confocal images of DRG explants and their neurites stained in green. (B): Quantiﬁcation of the neurite area with
ImageJ software. (C): Analysis of the arborization patterns produced by each experimental group. Only ASCs’ secretome was able to
induce neurite outgrowth on DRG explants, while OECs secretome and the control did not present a signiﬁcant neurite formation. (D):
Proteomic analysis performed for ASCs’ and OECs’ secretome. The proteins identiﬁed are involved in several different pathways, some of
which are responsible for processes such as neuronal outgrowth and neuroprotection. Scale: 100 mm; Values are shown as mean6 SEM
(n5 6 replicates); *, p .05; **, p .01. Abbreviations: ASCs, adipose tissue-derived stromal cells; OECs, olfactory ensheathing cells.
Gomes, Mendes, Assunc¸~ao-Silva et al. 701
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In particular, the mean BBB score was statistically different
at 2, 3, 4, 5, 7, and 8 weeks post-injury (Fig. 4B). In addition,
sham animals did not present motor deﬁcits during this
period. After a detailed analysis on the BBB test, we con-
cluded that the main differences between Cells and HS groups
were in the stepping capability, coordination, and toe clear-
ance (Fig. 4C). Transplanted rats presented higher stepping
scores, meaning that were capable of doing plantar steps
while nontreated rats did mostly dorsal steps. They also
showed more frequent coordinated steps and a tendency to
perform better in toe clearance. No differences were
observed in parameters such as the position of the paw, tail
position, and trunk instability (data not shown).
No signiﬁcant differences between cells-treated and non-
treated rats were found in the total distance measurements
(Fig. 5A) and in the number of rearings (Fig. 5B), both evalu-
ated at zero and 8 weeks post-injury. However, it is interesting
to notice that in rearing behavior, sham animals are only sig-
niﬁcantly different in comparison to the nontreated group
(HS), at 8 weeks post-injury, a fact that can be interpreted as
indicative of the relevance of the ASCs/OECs based therapy.
A similar result was observed in the swimming test (Fig.
5C) performed 8 weeks post-injury. HS group was not signiﬁ-
cantly different from Cells’ transplanted group; however, sham
animals presented a signiﬁcantly higher average velocity in
water, only when compared with nontreated animals.
Transplantation of ASCs and OECs Reduces the
Infiltration of Inflammatory Cells
Eight weeks after the injury, IHC against CD11b/c revealed
that the area occupied by inﬂammatory cells in regions close
to the injury site was signiﬁcantly increased in the HS group
(18,7656 3,932 mm2) in comparison to the levels of the sham
group (5,5906 1,606 mm2), and to rats cotransplanted with
ASCs and OECs (7,5486 525 mm2, Fig. 6A, 6B). This indicates
that ASCs/OECs treatment was apparently preventing the inﬁl-
tration of inﬂammatory cells, which partially explains the
functional results obtained. In the contralateral side to the
lesion, there were no differences between groups in the area
of CD11b/c (data not shown). IHC against GFAP revealed a
similar trend, although there were no signiﬁcant differences
among groups (Fig. 6A, 6C). Nevertheless, injured rats present
higher levels of astrogliosis than sham animals, while
treatment with cells provides an evident reduction in those
values.
Transplanted ASCs Were Present in the Spinal Cord
Eight Weeks after Transplantation
An IHC against HuNu was performed in order to identify
transplanted ASCs, since it is a speciﬁc marker for human
cells. In fact, results showed that ASCs were still present at
the spinal cord, 8 weeks post-transplantation (for all
Figure 4. Locomotor recovery assessed by the BBB test, during 8 weeks of follow-up. (A): Schematic representation of the T10 left hemisec-
tion injury induced. (B): Mean BBB score of the different experimental groups. (C): Evaluation of three different parameters used in the BBB
subscore: stepping, coordination, and toe clearance. Cells-treated animals presented signiﬁcant improvements of BBB score, in different
time points, in comparison to nontreated (HS) animals. Values are shown as mean6 SEM (n5 5); *, p .05; **, p .01. Abbreviations: BBB,
Basso, Beattie, Bresnahan Locomotor Rating Scale; HS, hemisection.
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transplanted animals). These cells could mostly be found in
regions close to the injury site, or where there was high inﬁl-
tration of cells (Fig. 7).
DISCUSSION
The use of cellular therapies in SCI research has been widely
explored [39]. Several different types of cells have already
been tested [40] and even numerous clinical trials have been
done or are still ongoing [14, 41, 42]. The big advantage of
the cells used in our therapeutic approach is their accessibility
and easy translatability to the clinics. Despite of the promising
results demonstrated by the solo transplantation of ASCs or
OECs in other works [12, 13, 20, 22], the combined adminis-
tration of these two speciﬁc cell populations has rarely been
tested. In addition, the mechanisms by which they act remain
elusive. In order to understand ASCs and OECs inﬂuence on a
speciﬁc phenomenon such as neurite outgrowth, we started
by using DRG explants as a model of axonal regeneration
[35].
From the data obtained, we can conclude that OECs pro-
vide better support to guided neurite outgrowth than ASCs,
producing massive neurite arborizations (Figs. 1, 2). On the
other hand, when we used the secretome of the cells, the
only one capable of inducing neurite formation was ASCs CM
(Fig. 3). This could mean that both ASCs and OECs have the
potential to induce neurite formation, but their main mecha-
nism of action might be different. For instance, in a study
from Leaver et al. [43] olfactory ensheathing glia (OEG) also
induced signiﬁcant increases in the number and extension of
neurites from retinal explants, in that case in comparison to
Schwann cells (SCs). This enhanced growth was also suggested
to be contact-mediated since conditioned media from OEG
did not present the same effects [43]. Another example of
contact mediated increase of axonal outgrowth induced by
OECs includes DRG axons grown on myelin substrates [44]. In
our study, the secretome of OECs did not reveal to be a
growth promoting substrate for axonal outgrowth of DRG
explants, even though there is a substantial body of literature
supporting the relevance of OECs’ secreted factors in axonal
regeneration context [45–47]. The contact-mediated ability of
OECs might be partially due to the action of metalloprotei-
nases (MMPs) such as MMP-2, MMP-3, and MT1-MMP, which
seem to play a role on cellular motility and on their neurotro-
phic properties [48]. Meanwhile, the secretome of ASCs has
been characterized by our group and others and it is known
to contain several axonal-growth factors, such as nerve
growth factor (NGF), glia-derived nexin, or semaphorin 7A, as
well as factors related to neuronal differentiation such as pig-
ment epithelium-derived factor [6, 10, 34, 49]. Some of these
Figure 5. General locomotor activity measured by the activity box test and swimming test. Average distance travelled by each group
(A) and total number of rearings (B) in the activity box test, both at zero and 8 weeks post-injury. There are no signiﬁcant differences
between cells-treated and nontreated animals. (C): Average velocity for each experimental group measured in a swimming test, 8 weeks
post-injury. The transplantation of ASCs and OECs did not lead to an improvement of the average velocity in water of injured animals.
Values are shown as mean6 SEM (n5 5); *, p .05; **, p .01. Abbreviation: HS, hemisection.
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might be responsible for the effects observed in DRG
explants. Furthermore, after exploring our proteomic data
[34], we could ﬁnd in ASCs’ secretome proteins associated to
several different signaling pathways. From those, we highlight
the VEGF signaling pathway for instance, which has a key role
in angiogenesis [50] but also has been shown to promote
adult neurogenesis and neuronal cell migration by stimulating
endothelial cells in vascular niches to release cues for neural
stem cells [51]. The cell cycle regulator PI3K pathway also
plays a crucial role in neuronal cell survival and proliferation
being stimulated by growth factors such as NGF or brain-
derived neurotrophic factor [52, 53]. Finally, cadherin signaling
pathway is involved in central processes such as cell adhesion,
neurogenesis and synaptic plasticity [54–56] and importantly
it has been demonstrated to promote neurite outgrowth by
facilitation of ﬁbroblast growth factor (FGF) receptor signaling
[57]. Several other pathways are highly associated with our
secretome, namely the hypoxia response via hypoxia-inducible
factor, as well as the endothelial growth factor (EGF) signaling
pathway, or the FGF signaling pathway, which in general are
Figure 6. Immunohistochemistry results for CD11b/c and GFAP markers. (A): Representative confocal images of spinal cord longitudinal
sections, immunostained for CD11b/c (upper panel) and GFAP (lower panel). (B): Quantiﬁcation of CD11b/c and (C) GFAP markers’ area.
Injured animals (HS group) have signiﬁcantly increased levels of CD11b/c, while cells-treated animals present values close to those of
sham animals. Values are shown as mean6 SEM (n5 5); *, p .05. Abbreviations: GFAP, glial ﬁbrillary acidic protein; HS, hemisection.
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implicated in neurite outgrowth, neurogenesis, neuroprotec-
tion and in many cellular processes that may contribute to
SCI regeneration. Proteins involved in neuronal communica-
tion pathways, such as the dopamine receptor-mediated sig-
naling pathway, are also present in ASCs secretome.
Moreover, by exploring reactome pathways (Supporting Infor-
mation Table 1) we could highlight the possible role of neural
cell adhesion molecule 1 (NCAM1) pathway in ASCs mediated-
neurite outgrowth. ASCs secretome was enriched in proteins
directly or indirectly related to NCAM1. This molecule modu-
lates neuronal cell adhesion, survival, and synaptic plasticity
among others. We found 14-3-3 protein which blocks neuro-
nal apoptosis [58]; ﬁbronectin, a main component of the
ECM, responsible for cell adhesion through integrin activation
[59]; or spectrin, implicated in the normal morphology of neu-
ron cell bodies and neurites [60]. Additionally, the semaphorin
receptor protein neuropilin-1 (in its soluble form [61] or
released through exosomes [62]), which is involved in axonal
guidance mechanisms, was also present in our sample [63].
On the other hand, our proteomic analysis of OECs secretome
shows in fact that different proteins were present, and conse-
quently associated to numerous signaling pathways. Neverthe-
less, none of them showed to be sufﬁcient to induce neurite
outgrowth of DRG explants. The absence of the VEGF path-
way, together with a reduction of neuronal communication
pathways or integrin signaling, could be responsible for the
lack of effects observed.
Considering the in vitro results herein obtained, we opted
to transplant ASCs and OECs together, so we could take advan-
tage from the contact-mediated regenerative capacity of OECs
and at the same time, beneﬁt from the neurite outgrowth and
neuroprotective properties associated to ASCs secretome. In
this study, the acute transplantation of ASCs and OECs led to
functional improvements, most evident in the BBB test. This
was associated with a marked decrease of CD11b/c marker and
a slight decrease of GFAP in areas close to the lesion. The
effect on microglial/inﬂammatory cells is supported by an in
vitro experiment in which ASCs and OECs secretome reduced
signiﬁcantly the number of CD11b/c cells in culture, revealing
that the factors secreted by both types of cells might mediate
this mechanism (Supporting Information Fig. 2). We did not see
differences in any other markers analyzed, namely NF for axons
or tyrosine hydroxylase for speciﬁc dopaminergic neurons
(Supporting Information Fig. 1). This excludes a direct effect of
OECs on neuronal rewiring, and supports the idea that OECs
might have worked as “feeders” supporters for ASCs growth,
as previously shown by our group in in vitro experiments [31].
Therefore, the functional improvements obtained were not
directly connected to preservation or regeneration of the neu-
ronal circuitry, but more linked to modulation of the injury
environment. In fact, a reduction of inﬂammation and astroglio-
sis has been previously associated with improvements in loco-
motor function [64, 65].
In the histological analysis, we could detect transplanted
ASCs, 8 weeks after injury. Their distribution seems to be
restricted to regions close to the injury site, or in areas of vis-
ible cellular inﬁltration. In this sense, ASCs were able to
migrate from the injection sites to the injury site and were
integrated into the spinal cord tissue. The survival of ASCs 2
months after transplantation is an important ﬁnding because
this means that ASCs were able to exert their paracrine-based
effect over longer periods of time. As previously mentioned,
ASCs secrete immunomodulatory molecules, which associated
with their long survival may explain the decrease observed on
inﬂammation. Unfortunately, we could not trace transplanted
OECs. These cells share many markers with SCs and it is
known that SCs inﬁltrate the spinal cord after a lesion [66],
thus we could not distinguish between these two types of
cells. Nevertheless, cultures of OECs before transplantation
presented around 90% purity levels, based on ICC against p75
positive cells (Supporting Information Fig. 3).
Overall, our results unveil a beneﬁcial effect of transplant-
ing both ASCs and OECs after a SCI. However, many issues
remain to be clariﬁed regarding the application of these cell
populations in SCI. In the case of OECs, the inﬂuence of the
speciﬁc region from where they are isolated, the purity of the
cultures, and the existence of subtypes of OECs [16] are just
some examples of the variety existing in the literature. In
addition, for both ASCs and OECs it will be important to
understand which are the main mechanisms and molecules
mediating their effects, so one can take the maximum advan-
tage of these cells. Finally, it will be interesting to test the
transplantation of ASCs and OECs after the establishment of
the lesion, in a subchronic or chronic phase, or even combine
ASCs/OECs with a biomaterial or scaffold that can enhance
their survival in the hostile environment existing after a SCI.
Figure 7. Confocal images depicting adipose tissue-derived stem cell ([ASCs] stained for HuNu, in green) present at the site of injury.
ASCs might have migrated from the injection sites to the border of the hemisection injury.
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CONCLUSION
Cellular therapies for SCI treatment are one of the most
explored strategies in preclinical research. The choice of a cell
population suitable for transplantation needs to take into
account not only its potential therapeutic effect but also its
translatability into a clinical setting. In this context, ASCs and
OECs could be an interesting solution.
From this work, it is possible to conclude that both ASCs
and OECs have the potential to induce neurite outgrowth in a
DRG explant model, even though their main mechanism of
action might be different. If on one side, OECs seem to pro-
vide physical support and guidance for neurite outgrowth and
elongation, ASCs on the other hand may secrete different
molecules that potentiate neurite formation and growth,
assuming a more paracrine role on neuritogenesis. In addi-
tion, their combined administration into an animal model of
SCI resulted in signiﬁcant improvements of locomotor behav-
ior and a marked reduction of inﬂammatory cells. Neurite out-
growth was not observed at the lesion site, which may
suggest a more supportive role for OECs in vivo, instead of a
rewiring of the neuronal network. Importantly, ASCs could be
detected 2 months post-transplantation. In summary, the
acute transplantation of ASCs and OECs after a SCI is a prom-
ising and easily translatable approach that with the proper
reﬁnements, could lead to a signiﬁcant amelioration of
patients suffering from SCI.
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